Literature DB >> 7791284

[Early vitrectomy in endogenous juvenile uveitis intermedia--a long-term study].

P Kroll1, F Romstöck, U H Grenzebach, W Wiegand.   

Abstract

BACKGROUND: The intermediate uveitis is one of the most common intraocular manifestations of inflammation during infancy and adolescence. The success of intensive pharmacological treatment is rather limited and often associated with heavy side effects. PATIENTS AND METHODS: In 25 eyes with juvenile uveitis intermedia (age of the patients between 5 and 18 years, mean 13.5 years) and visual acuities between 0.02 and 0.4 (mean 0.19) an early vitrectomy was performed after failure of conservative treatment and peripheral cryocoagulation.
RESULTS: Almost all patients (22 out of 25) showed an improvement of visual acuity within the first 6 months of the surgery. Among the patients with a remarkable improvement of visual acuity 7 eyes had a chronic cystoid macular oedema which showed a regression postoperatively. Additionally, the number and the course of inflammatory periods could be reduced postoperatively. An increase of preexisting lens opacities, however, has not been noticed even after a follow-up period of 10 years.
CONCLUSIONS: The results show that an early vitrectomy in cases of juvenile uveitis intermedia often leads to a stabilization or an improvement of visual acuity and a regression of the inflammatory attacks (episodes). Therefore, in children and adolescents with endogenous uveitis intermedia a pars plana vitrectomy instead of a long-term systemic immunosuppression associated with heavy side-effects should be considered.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791284     DOI: 10.1055/s-2008-1035433

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

1.  Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations.

Authors:  Matthias Gutfleisch; Georg Spital; Anne Mingels; Daniel Pauleikhoff; Albrecht Lommatzsch; Arnd Heiligenhaus
Journal:  Br J Ophthalmol       Date:  2006-09-27       Impact factor: 4.638

Review 2.  [Therapeutic vitrectomy in uveitis: current status and recommendations].

Authors:  M D Becker; N Harsch; M Zierhut; J L Davis; F G Holz
Journal:  Ophthalmologe       Date:  2003-10       Impact factor: 1.059

3.  Preoperative Inflammatory Control and Surgical Outcome of Vitrectomy in Intermediate Uveitis.

Authors:  Yong Un Shin; Joo Young Shin; Dae Joong Ma; Heeyoon Cho; Hyeong Gon Yu
Journal:  J Ophthalmol       Date:  2017-03-30       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.